IPOPLUS

₹87

▲ +0.9 +1.05%

11 May 2026

NSE Listed

Nephro Care Limited (NEPHROCARE)

Volume: 8,000Avg Vol 1W: 13,200Avg Vol 1M: 15,88052W Range:₹50.05₹183
NSE BSE
₹87▲ 1.05%
Key Ratios
Updated 5h ago
Market Cap₹115 Cr
Current Price₹87
Previous Close₹86.1
High / Low (52w)₹183 / ₹50.05
Volume8,000
Avg Vol (1W)13,200
Avg Vol (1M)15,880
Stock P/E142.62
Book Value₹34.48
Dividend Yield0%
ROE5.9%
ROA1.4%
Revenue (TTM)₹48 Cr
Revenue Growth—
Profit Margin3.7%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0.61
P/B2.02
Debt / Equity0
50 DMA₹73.76
200 DMA₹116.8
Day change+1.05%
Price Chart
₹87▼ 31.47% · 1Y
₹174₹523.5L
2025-06-17
2026-05-11

20-day avg volume: 16K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 70% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 143.
Quarterly Results
MetricDec 2025Mar 2026
Revenue₹23 Cr₹27 Cr
EBITDA₹1 Cr₹1 Cr
Net Profit₹0 Cr₹1 Cr
EPS——
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹1 Cr₹2 Cr₹3 Cr₹17 Cr₹28 Cr₹48 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹6 Cr₹5 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹4 Cr₹4 Cr
EPS——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1 Cr₹1 Cr₹5 Cr₹8 Cr₹21 Cr₹68 Cr
Total Liabilities₹1 Cr₹1 Cr₹4 Cr₹6 Cr₹6 Cr₹15 Cr
Equity₹0 Cr₹0 Cr₹1 Cr₹3 Cr₹15 Cr₹53 Cr
Total Debt₹0 Cr₹1 Cr₹2 Cr₹2 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹1 Cr₹4 Cr₹3 Cr₹9 Cr
Investing₹0 Cr₹-3 Cr₹-2 Cr₹-8 Cr₹-40 Cr
Financing₹0 Cr₹2 Cr₹0 Cr₹6 Cr₹35 Cr
Free Cash Flow₹0 Cr₹1 Cr₹4 Cr₹3 Cr₹9 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search